Lillian Smith, Adherence and Supervision Coordinator (MAPS PBC)

Lillian Smith earned a bachelor’s degree in neuroscience with a minor in public health from Boston University in 2013. As an undergraduate, Lillian interned at the World Health Organization in Geneva, Switzerland, working on European pharmaceutical policy. Following graduation, she worked in Nobel laureate Susumu Tonegawa’s lab at the Massachusetts Institute of Technology where she used optogenics to study the neural circuitry involved in learning and memory. Lillian was most recently a preclinical researcher at Decibel Therapeutics in Boston, where she helped discover new therapies to treat hearing loss and other inner ear disorders.
At MAPS PBC, Lillian is an Adherence and Supervision coordinator, supporting the oversight of therapists involved in MAPS-sponsored trials of MDMA-assisted psychotherapy. She focuses on the coordination of Adherence and Supervision programs for the MP18 trial in Europe. MP18 is a Phase 2 trial (open-label) that will lead into MAPP3, our Phase 3 (RCT) trial in Europe.
Lillian is a dedicated meditator and has lived as a resident at the Cambridge Zen Center in Cambridge, MA., for more than two years. As part of her residency, she helps to support meditation retreats and leads several meditation groups, including a bi-weekly group at the Women’s Prison in Framingham, MA. Lillian is currently completing her Level 2 meditation instructor training through Unified Mindfulness.
Lillian is thrilled to have the opportunity to be involved with such a cutting-edge clinical trial. She is excited about the unlocked potential of psychedelics to change the way we treat trauma and mental illness.
In her free time, Lillian is a dedicated cyclist and rower. She loves cooking and spending time with her family on their organic farm in Wisconsin.